1Ross R. At heroselerosis 2 an inflammatory disease [J] . N Engl J Med, 1999,340 (2):B115--124.
2Koenig W. Inflammation and coronary heart disease: a nover 2 view[J]. CardiolRev,2001,9 (1):31--35.
3Mach F, Schonbeck U, Bonnefoy JY, et al. Activation of mono cyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor[J]. Circulation, 1997,96 : 396- 399.
4Karpsas M, Hsu YM, Wang JH, et al. A crystal structure of an extraeellular fragment of human CD40 ligand[J]. Structure, 1995,3:1031--1039.
5Banchereau J, Bazan F, Blanchard D, et al. The CD40 antigen and itsligand[J]. Annu Rev Immunol, 1994, 12:881 -- 922.
6Gerritse K, Laman JD, Noelle RJ, et al. CIM0--CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis[J]. J Proc Natl Acad Sei USA,2000,473(2) :149--159.
7Szabolcs MJ, Cannon PJ, Thienel U, et al. Analysis of CD154 and CD40 expression in native coronary atherosclerosis and transplant associated Coronary artery disease[J]. J Virchows Arch, 2000, 437(2) :149--159.
8Ross R. Atherosclerosis an inflammation disease[J]. J N Engl Med, 1999,340 : 115-- 126.
9Mach F, Schonbeck U, Sukhova GK, et al. Functional CD40 ligand is expressed on human vascular endothelial ceils, smooth muscle cells, and macrophages :Implication for CD40--CD40 ligand signaling in atherosclerosis[J]. J Proc Natl Acad Sci USA, 1997,94: 1931--1936.
1Schonbeck U, Libby P. CD40 signaling and plaque instability[J]. Circ Res, 2001, 89(12):1092-1103 .
2Lutgens E,Daemen MJ.CD40-CD40L interactions in atherosclerosis[J].Trends Cardiovasc Med,2002,12(1):27-32
3Kumanogoh A, Wang X, Lee I, et al. Increase T cell autoreactivity in the absence of CD40 - CD40L ligand interaction: A role of CD40 in regulatory T cell development[J] .J Immunol,2001, 166(1):353-360.
4Garia JGN, Painter RG, Fenton JW, et al.Thrombin-induced prostacyclin biosynthesis in human endothelium:Role of guanine necleotide regulatory proteins in stimulus/coupling responses[J].J Cell Physiol,1990,142(7):186-193
5Sugiyama S,Okada Y,Sukhova GK,et al.Macrophage myeloperoxidase regulation by granulocyte macrophage colonystimulating factor in human atherosclerosis and implications in acute coronary syndromes[J].Am J Pathol,2001,158(3):879-891
6Yan JCh, Wu ZG, Huang Zh, et al. Clinical implications of increased expression of CD40L in patients with acute coronary syndromes[J]. Chin Med J, 2002, 115(4):491-493
7Frestegard F, Ulfgren AK, Nyberg P, et al. Cytokine expression in advanced human atherosclerotic plaques:dominance of pro- inflammatory and macrophage- stimulating cytokines[J]. Atherescleresis, 1999, 145(1):33-43.
8Schonbeck U, Libby P. CIMO signaling and plaque instability[J].Circ Res, 2001, 89(12):1092-1103.
9Schonbeck U, Sukhova GK, Schonbeck U, et al. Inhibition of CD40 signaling limits evolution established atheroselerosis in mice[J]. Proc Nail Acad Sci USA, 2000, 97(13):7458-7463.